Lisa Olivo, Associate Editor04.01.15
Arthritis is the most prevalent long-term disability in the U.S., according to the Centers for Disease Control and Prevention (CDC). The National Health Interview Survey (NHIS) for 2010-2012 found that approximately one in five (22.7%) American adults reported having doctor-diagnosed arthritis. For adults aged 65 or older, this percentage skyrocketed to 49.7%; 30.3% for U.S. adults aged 45-64; 7.3% for those 18-44.
The burden of this disease will impact an even greater portion of the population, according to the CDC, as the number of Americans over 65 grows to 20% of the population—or nearly 72 million—by the year 2030. By this time, NHIS forecast that 67 million U.S. adults 18 and older will have doctor-diagnosed arthritis.
The widespread prevalence of this inflammatory joint disease, along with a growing aging population, has made joint health a primary concern among consumers.
With an array of supplements available to soothe and protect joints, those looking to stave off age-related inflammation or arthritis have many options. However, new introductions and an evolving c
The burden of this disease will impact an even greater portion of the population, according to the CDC, as the number of Americans over 65 grows to 20% of the population—or nearly 72 million—by the year 2030. By this time, NHIS forecast that 67 million U.S. adults 18 and older will have doctor-diagnosed arthritis.
The widespread prevalence of this inflammatory joint disease, along with a growing aging population, has made joint health a primary concern among consumers.
With an array of supplements available to soothe and protect joints, those looking to stave off age-related inflammation or arthritis have many options. However, new introductions and an evolving c
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
